Overview
Indobufen has been used in trials studying the supportive care and prevention of Atrial Fibrillation.
Indication
用于动脉硬化引起的缺血性心血管病变、缺血性脑血管病变、静脉血栓形成。也可用于血液透析时预防血栓形成。
Associated Conditions
- Platelet Aggregation
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2024/06/11 | Phase 4 | Not yet recruiting | Shanghai Zhongshan Hospital | ||
2021/11/03 | Phase 4 | UNKNOWN | |||
2020/03/16 | Not Applicable | Withdrawn | Henan Institute of Cardiovascular Epidemiology | ||
2019/10/16 | Phase 4 | UNKNOWN | Beijing Anzhen Hospital | ||
2019/03/12 | Phase 4 | Completed | Beijing Tiantan Hospital | ||
2017/07/27 | Phase 4 | UNKNOWN | |||
2010/11/02 | Phase 1 | UNKNOWN | |||
2005/10/26 | Phase 3 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Indobufen Tablets | 国药准字H20253400 | 化学药品 | 片剂 | 2/20/2025 | |
Indobufen Tablets | 国药准字H20253399 | 化学药品 | 片剂 | 2/20/2025 | |
Indobufen Tablets | 国药准字H20253852 | 化学药品 | 片剂 | 4/8/2025 | |
Indobufen Tablets | 国药准字H20253943 | 化学药品 | 片剂 | 4/15/2025 | |
Indobufen Tablets | 国药准字H20244297 | 化学药品 | 片剂 | 6/28/2024 | |
Indobufen Tablets | 国药准字H20249478 | 化学药品 | 片剂 | 12/1/2024 | |
Indobufen Tablets | 国药准字H20244933 | 化学药品 | 片剂 | 9/19/2024 | |
Indobufen Tablets | 国药准字H20244906 | 化学药品 | 片剂 | 9/19/2024 | |
Indobufen Tablets | 国药准字H20243075 | 化学药品 | 片剂 | 1/23/2024 | |
Indobufen Tablets | 国药准字H20244907 | 化学药品 | 片剂 | 9/19/2024 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.